Cargando…
B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
DNA vaccines have been an attractive approach for treating cancer patients, however have demonstrated modest immunogenicity in human clinical trials. Dendritic cells (DCs) are known to cross-present DNA-encoded antigens expressed in bystander cells. However, we have previously reported that B cells,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190194/ https://www.ncbi.nlm.nih.gov/pubmed/37205983 http://dx.doi.org/10.1080/2162402X.2023.2212550 |